Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine.
De Giovanni C, Nicoletti G, Landuzzi L, Astolfi A, Croci S, Comes A, Ferrini S, Meazza R, Iezzi M, Di Carlo E, Musiani P, Cavallo F, Nanni P, Lollini PL.
De Giovanni C, et al. Among authors: nanni p.
Cancer Res. 2004 Jun 1;64(11):4001-9. doi: 10.1158/0008-5472.CAN-03-2984.
Cancer Res. 2004.
PMID: 15173014